Innovator Capital is a boutique investment bank advising emerging Biomedical and Environmental technology companies regardless of their nationality. We were established in 2003 and focus on the provision of expert strategic and capital markets advice, transaction arranging and M&A services for private and public companies.

We address the continuing unsatisfied capital requirement and other needs by assisting companies with their understanding of the numerous alternatives and opportunities available around the world. Innovator Capital's objective is to provide a high value-added approach to capital raising, partnering, product licensing and other key issues.

Innovator develops tailor-made solutions to satisfy companies' individual requirements such as, situations where a company's valuation is perceived to be below reasonable levels. These solutions are executed bearing in mind the limited amount of time that managements have to devote to non-operational activities, they may then concentrate on the execution of their business plans rather than spend time looking for capital or lifting awareness of their organisations.

Innovator Capital has various new approaches to funding companies, which have been proven in numerous world financial centres. The approaches allow companies to determine the precise timing and scale of their access to the capital markets, while delivering greater direct control over pricing. Innovator benefits from: the track record and multinational expertise of our founder; the breadth and depth of knowledge across the firm; the edge we have as a result of different and objective use of the capital markets; and the nature of the business model we follow in multiple financial markets.

We are at the forefront of innovation.

Contact Us >>